Mark Verrill Consultant Medical Oncologist, Northern Centre for Cancer Care, Newcastle-upon-Tyne Sessions Future vision for systemic therapies 14:50 - 15:00 Welcome and Introduction 16:00 - 16:05 Molecular mechanisms of primary & acquired resistance to endocrine therapy: the way forward 16:05 - 16:25 Welcome and Introduction 17:30 - 18:00 Summary of the RxPONDER publication 17:30 - 18:00 Case Study Discussion – What does this mean for patients? 17:30 - 18:00
